Specifically, remdesivir showed a significant reduction in hospitalization and respiratory failure, while for ICU admission and mortality, there was a favorable trend, although the wide confidence interval and lack of statistical significance suggest insufficient evidence.
← all excerpts
Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis.
1
—
—